12 results
Keyword ronapreve Remove keyword
Categories
Human Remove Human filter
Type of content
News Remove News filter
-
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 6 - 9 February 2023
PRAC, Last updated: 10/02/2023 -
List item
News: ETF warns that monoclonal antibodies may not be effective against emerging strains of SARS-CoV-2
Last updated: 09/12/2022Regkirona (regdanvimab), Ronapreve (casirivimab / imdevimab … https://www.ema.europa.eu/documents/overview/evusheld-epar-medicine-overview_en.pdf 2: Ronapreve EPAR Ronapreve | European Medicines Agency … -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 26-29 September 2022
PRAC, Last updated: 30/09/2022 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 29 August – 1 September 2022
PRAC, Last updated: 02/09/2022 -
List item
News: EMA publishes annual report 2021
Last updated: 10/06/2022 -
List item
News: EMA adopts first list of critical medicines for COVID-19
Last updated: 08/06/2022 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 2-5 May 2022
PRAC, Last updated: 06/05/2022 -
List item
News: Human medicines: highlights of 2021
Last updated: 15/02/2022Janssen Nuvaxovid Regkirona Ronapreve Spikevax Vaxzevria Xevudy Covid-19 Hukyndra Icatibant … -
List item
News: COVID-19: EMA recommends authorisation of antibody medicine Xevudy
CHMP, Last updated: 16/12/2021approval of Regkirona and Ronapreve in November. Monoclonal antibodies … -
List item
News: COVID-19: EMA recommends authorisation of two monoclonal antibody medicines
CHMP, Last updated: 12/11/2021News 11/11/2021 Ronapreve and Regkirona are now authorised … has recommended authorising Ronapreve (casirivimab/imdevimab) and … Committee recommended authorising Ronapreve for treating COVID-19 in … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 8-11 November 2021
CHMP, Last updated: 12/11/2021Ronapreve … -
List item
News: EMA receives application for marketing authorisation for Ronapreve (casirivimab / imdevimab) for treatment and prevention of COVID-19
CHMP, PDCO, PRAC, Last updated: 11/10/2021marketing authorisation for Ronapreve (casirivimab / imdevimab … marketing authorisation for Ronapreve (casirivimab / imdevimab …